Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. NAUT.NASDAQ

Nautilus Biotechnology Inc (NAUT NASDAQ) stock market data APIs

$2.9 -0.02(-0.7%) as of July 26, 2024
Price chart is built with Anychart

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Nautilus Biotechnology Inc Financial Data Overview

2.92
2.9
-
2.92
2.86
2.19-4
358 M
125 M
0
-0.15
1.021
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NAUT',
Type: 'Common Stock',
Name: 'Nautilus Biotechnology Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00W7G4M12',
ISIN: NULL,
CUSIP: NULL,
CIK: '1808805',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-06-10',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Nautilus Biotechnology Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -77 719 000
  • Earnings Per Share -0.54
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Nautilus Biotechnology Inc Earnings via APIs

  • Latest Release 2024-04-30
  • EPS/Forecast -0.16

Get Nautilus Biotechnology Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Nautilus Biotechnology Inc latest news via APIs

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

SEATTLE, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteo...
  • CONTESTS/AWARDS
  • NASDAQ:NAUT
  • NAUTILUS BIOTECHNOLOGY INC

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

SEATTLE, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteo...
  • DIRECTORS AND OFFICERS
  • NASDAQ:NAUT
  • NAUTILUS BIOTECHNOLOGY INC
Do you have any questions?
support@eodhistoricaldata.com